Novel circadian clock activators display anti-obesity efficacy via suppression of adipocyte development and hypertrophy.

No SJR dataJan 16, 2026bioRxiv : the preprint server for biology

New circadian clock activators may reduce obesity by slowing fat cell growth and enlargement

AI simplified

Abstract

Chlorhexidine and a new derivative, CM002, may inhibit adipocyte development and promote anti-obesity effects.

  • Clock-activating molecules activate core clock components and shorten the clock period length in adipocytes.
  • These compounds suppress the commitment and differentiation of adipogenic precursor cells through Wnt signaling activation.
  • CM002 reduces lipid storage and adipocyte growth by inhibiting lipogenic and adipogenic processes in a clock-dependent manner.
  • Administration of CM002 in mice with diet-induced obesity activates the clock in fat tissues, leading to decreased adipogenic factors and enzymes.
  • CM002 demonstrates anti-obesity efficacy by reducing fat mass and improving insulin sensitivity.

AI simplified